Clinical Study to Generate a Set of Data Characterising Clinical Events, Physiological Responses, and Innate and Adaptive Immune Responses Following a Single IM Immunisation With Boostrix® or Placebo in Healthy Adults

Trial Profile

Clinical Study to Generate a Set of Data Characterising Clinical Events, Physiological Responses, and Innate and Adaptive Immune Responses Following a Single IM Immunisation With Boostrix® or Placebo in Healthy Adults

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Jun 2017

At a glance

  • Drugs DTaP vaccine (Primary)
  • Indications Bordetella infections
  • Focus Adverse reactions
  • Acronyms BioVacSafe - Boostrix
  • Most Recent Events

    • 06 Jun 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 06 Jun 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 13 Aug 2016 New source identified and integrated (European Clinical Trials Database; EudraCT2015-002879-14).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top